- Walgreens partners with United Nations Foundation's Shot@Life campaign
- Study: Cough-cold manufacturers' voluntary label change on pediatric products reduced ER admissions
- Pain Relief 2013
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Walgreens partners with Chicago Public Schools and city health department on Tdap vaccination project
BASKING RIDGE, N.J. — Mylan subsidiary Dey Pharma has launched a mobile application for patients at risk of severe allergic reactions, which is tied to its EpiPen product.
The MyEpiPen app is available for the Apple iPhone, iPod Touch and iPad, and allows individuals, parents, guardians and others to create and share profiles of severe allergies with friends, family, teachers, school nurses, babysitters and others. Other features include an instructional video, user guide and others.
“Mylan and Dey Pharma have been steadfast in our long-standing commitment to meeting unmet needs,” Dey COO Lloyd Sanders said. “Toward that effort, we are very excited about the MyEpiPen apps, as they will provide a portable and accessible tool to equip individuals and caregivers with valuable information they may need to care for themselves and others in the event of an allergic emergency.”